World

Meta plans to buy chip startup Rivos to boost semiconductor efforts

Oct 01, 2025

New York [US], October 1: Meta (META.O), opens new tab intends to acquire the chip startup Rivos to bolster its in-house semiconductor efforts, the social media company said.
The Santa Clara, California-based startup, which is backed by Intel (INTC.O), opens new tab CEO Lip-Bu Tan, is focused on designing chips based on the RISC-V architecture, an open-source alternative to the architectures made by Arm, Intel and AMD (AMD.O), opens new tab.
Meta declined to disclose the financial terms and Rivos did not immediately respond to a Reuters request for comment.
Rivos brings expertise in building full-stack AI systems, Meta's vice president of engineering Yee Jiun Song said in a LinkedIn, opens new tab post.
Meta aims to expand work on the Meta Training and Inference Accelerator (MTIA), its family of custom-built in-house chip accelerators, he said.
The chip startup was near new funding at about a $2 billion valuation, a source told Reuters earlier.
Meta has been one of Rivos' biggest customers and had been talking to the startup about a deal, a second source familiar with the matter said. The sources declined to be named as they were not authorized to discuss the information.
Reuters exclusively reported in March that Meta was testing its first in-house chip for training AI systems as the company seeks to cut infrastructure costs linked to its spending on advanced AI tools.
The Instagram and Facebook owner has been spending heavily on sought-after AI chips from Nvidia.
Bloomberg News first reported about Meta's intention to buy Rivos.
Source: Fijian Broadcasting Corporation

More news

Clinicians at Fortis' S.L. Raheja Hospital Successfully Perform 1st Bone Marrow Transplant, Marking a Major Milestone in Advanced Cancer Care

Mumbai (Maharashtra) [India], October 20: S.L. Raheja Hospital, Mahim - A Fortis Associate, has achieved a milestone in its clinical journey with the successful completion of its first-ever Bone Marrow Transplant (BMT) at the COE for Haemato-Oncology. The landmark procedure was performed on a critically ill 61-year-old patient named Bijayentimala Devi from Manipur diagnosed with Multiple Myeloma, a complex form of blood cancer. The patient underwent an autologous stem cell transplant, which has led to a remarkable improvement in health, weight gain, and overall well-being -- bringing renewed hope to patients suffering from serious haematological conditions.

Oct 20, 2025